AXIM Biotech Retains Ora to Manage Upcoming Product Development and Clinical Trials on Glaucoma and...
Ophthalmic Product Development Insights
A look at ocular/nasal interactions and how they can affect our pharmaceutical therapies.
A look at the latest research from multiple corners of ophthalmology, from gene therapy to dry eye.
Cutting-edge progress also continues in retina, cornea, dry eye, gene-based science
A rundown of the most interesting research in a variety of subspecialties presented at this year’s ARVO meeting.
The placid ocular surface is actually teeming with life that might hold the secret to treating ophthalmic disease.
Customer Success Stories: Celebrating Your Big Wins in 2014-2015
How chronic glaucoma treatment can give rise to ocular surface disease, and how you can treat them both.